Financial toxicity is increasingly recognised as an adverse outcome of cancer treatment. For 240 respondents, financial toxicity was correlated with worse self-reported health.
Government-sponsored health insurance, lower income, and treatment with chemotherapy were significantly associated with high financial toxicity. Amongst those with excellent insurance coverage and high reported incomes, many respondents reported high levels of financial toxicity.
High financial toxicity was significantly associated with worse self-reported overall health and cost-coping strategies, including delaying or avoiding care. Health insurance does not eliminate financial distress or health disparities for cancer patients.